Indoco Remedies Ltd

₹ 405 1.19%
Jan 27 10:05 a.m.
indoco.com BSE: 532612 NSE : INDOCO
About

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).[1]

[ add key points ]
Website BSE NSE
  • Market Cap ₹ 3,733 Cr.
  • Current Price ₹ 405
  • High / Low ₹ 530 / 274
  • Stock P/E 28.5
  • Book Value ₹ 90.7
  • Dividend Yield 0.36 %
  • ROCE 15.6 %
  • ROE 12.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 4.41 times its book value
  • The company has delivered a poor sales growth of 4.30% over past five years.
  • Company has a low return on equity of 5.54% for last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
263 252 253 292 289 272 276 328 332 305 386 387
238 223 230 260 254 239 227 267 272 250 300 300
Operating Profit 25 29 23 32 35 33 49 60 60 55 87 86
OPM % 9% 11% 9% 11% 12% 12% 18% 18% 18% 18% 22% 22%
Other Income 1 5 1 1 1 0 0 1 0 2 1 1
Interest 4 5 6 5 7 8 6 6 6 5 4 3
Depreciation 18 19 17 18 18 18 19 19 17 19 22 19
Profit before tax 4 9 0 9 11 8 24 36 37 33 61 65
Tax % -37% -24% -679% 21% 17% 31% 29% 31% 33% 26% 35% 36%
Net Profit 5 12 2 7 9 5 17 25 25 25 40 42
EPS in Rs 0.58 1.26 0.24 0.80 1.01 0.59 1.87 2.72 2.73 2.70 4.30 4.51
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 TTM
402 480 568 629 726 851 1,005 1,072 1,038 968 1,106 1,240 1,410
348 412 483 536 606 686 834 915 903 891 982 1,016 1,122
Operating Profit 54 68 85 93 120 165 171 157 135 77 124 224 288
OPM % 13% 14% 15% 15% 17% 19% 17% 15% 13% 8% 11% 18% 20%
Other Income 4 6 2 1 2 2 1 4 5 6 2 3 4
Interest 3 4 16 22 19 10 12 6 24 21 26 22 18
Depreciation 12 13 19 24 31 47 61 63 68 72 71 73 77
Profit before tax 43 57 51 48 72 109 99 91 48 -9 29 131 197
Tax % 2% 10% 10% 12% 20% 24% 17% 15% 15% 69% 16% 30%
Net Profit 42 51 46 43 58 83 82 77 41 -3 24 92 131
EPS in Rs 4.58 5.56 5.04 4.63 6.28 8.99 8.93 8.41 4.47 -0.31 2.63 10.03 14.24
Dividend Payout % 20% 19% 15% 24% 22% 18% 18% 19% 22% -97% 11% 15%
Compounded Sales Growth
10 Years: 10%
5 Years: 4%
3 Years: 6%
TTM: 21%
Compounded Profit Growth
10 Years: 6%
5 Years: 2%
3 Years: 32%
TTM: 130%
Stock Price CAGR
10 Years: 22%
5 Years: 8%
3 Years: 30%
1 Year: 25%
Return on Equity
10 Years: 10%
5 Years: 7%
3 Years: 6%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Sep 2021
12 12 12 18 18 18 18 18 18 18 18 18 18
Reserves 298 338 368 396 439 500 558 633 657 643 662 750 817
Borrowings 66 99 114 118 91 94 139 280 282 296 262 258 263
103 114 157 157 178 229 224 266 280 301 330 289 335
Total Liabilities 479 563 652 689 726 842 939 1,197 1,238 1,258 1,272 1,317 1,434
197 213 302 321 325 339 373 440 489 468 590 570 610
CWIP 31 53 33 38 44 63 55 91 136 185 51 68 28
Investments 0 0 0 0 0 1 18 3 3 2 2 2 2
251 298 317 330 356 439 493 664 611 603 630 676 794
Total Assets 479 563 652 689 726 842 939 1,197 1,238 1,258 1,272 1,317 1,434

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
48 38 59 69 100 110 112 88 123 132 123 82
-47 -77 -64 -43 -41 -88 -113 -171 -135 -104 -56 -67
7 24 -7 -26 -58 -21 0 132 -39 -16 -64 -30
Net Cash Flow 9 -15 -12 -0 1 1 -0 50 -51 12 3 -14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 82 70 73 74 69 66 68 73 73 73 69 69
Inventory Days 142 141 152 129 147 179 173 188 204 209 230 245
Days Payable 86 82 111 87 87 137 129 159 158 195 184 119
Cash Conversion Cycle 139 129 114 116 129 107 111 102 119 88 115 195
Working Capital Days 123 96 88 90 83 81 85 90 94 84 76 106
ROCE % 13% 15% 14% 14% 17% 21% 17% 12% 7% 1% 6% 16%

Shareholding Pattern

Numbers in percentages

Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021
58.68 58.68 58.69 58.69 58.69 58.69 58.69 58.69 58.69 58.69 58.69 58.69
2.12 2.10 2.06 2.02 1.97 2.00 2.22 2.88 2.66 2.29 2.43 1.62
14.77 15.19 14.79 15.18 15.56 14.54 14.67 17.11 19.26 19.28 17.69 17.78
24.44 24.04 24.46 24.11 23.78 24.77 24.42 21.32 19.39 19.74 21.19 21.91

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls